Loading clinical trials...
Loading clinical trials...
Radicle Clarity™ 24: A Randomized, Double-Blind, Placebo-Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes
Conditions
Interventions
Placebo Control Form 1
Clarity Active Study Product 1.1 Usage
+15 more
Locations
1
United States
Radicle Science, Inc
Del Mar, California, United States
Start Date
March 4, 2024
Primary Completion Date
August 15, 2025
Completion Date
August 15, 2025
Last Updated
October 2, 2025
NCT04653012
NCT07071181
NCT04297020
NCT05556655
NCT05970588
NCT06353984
Lead Sponsor
Radicle Science
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions